– Dr. Harsha K Rajasimha
Alzheimers is surprisingly a poorly understood disease despite 5+ million Americans affected by it. Lack of proper diagnostic tests, poor understanding of disease progression and mechanisms involved need to be overcome before Biopharma has a successful drug for it. SAGA initiative by Alzheimers association commits 2+ million US dollars to study the role of sex and gender on Alzheimers. Women are at much higher risk than men for this disease – but reasons are poorly understood. https://www.genomeweb.com/genetic-research/alzheimers-association-commits-22m-fund-research-how-disease-affects-genders Can Information technology help accelerate Alzheimers research? Researchers have to navigate 100s of public and private databases and academic software tools for analyzing a variety of molecular, clinical, biomedical literature and drugs databases. @DellHealth, we are investing in the R&D powered by Dell Insights platform to help accelerate biopharma drug discovery and development R&D. Interested in a discussion? Happy to schedule an appointment.